BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 8073308)

  • 21. [Clinical features and treatment of Hodgkin's disease].
    Shirakawa S; Kita K; Kobayashi T; Ohno T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):421-34. PubMed ID: 3754108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
    Vuković I; Janković MB; Janić D; Stojimirović E
    Srp Arh Celok Lek; 1985; 113(11-12):1013-21. PubMed ID: 3841764
    [No Abstract]   [Full Text] [Related]  

  • 23. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Term pregnancy in a patient with Hodgkin's disease subjected to multi-chemotherapy treatment combined with radiotherapy (description of a typical case)].
    Migliavacca A; Petrocchi L; Perego C
    Ann Ostet Ginecol Med Perinat; 1986; 107(5):290-5. PubMed ID: 3827074
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hodgkin's disease in children; treatment results with or without radiotherapy].
    Behrendt H
    Ned Tijdschr Geneeskd; 1986 May; 130(19):865-8. PubMed ID: 3754935
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 27. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
    Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current methods of treating patients with lymphogranulomatosis, stages I and II].
    Shakhtarina SV
    Vopr Onkol; 1985; 31(8):10-21. PubMed ID: 3898577
    [No Abstract]   [Full Text] [Related]  

  • 30. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
    Baĭsogolov GD; Afanasova NV; Shakhtarina SV
    Med Radiol (Mosk); 1990 May; 35(5):10-3. PubMed ID: 2342405
    [No Abstract]   [Full Text] [Related]  

  • 32. [Controversial aspects in the current treatment of Hodgkin's disease].
    Vicente J
    Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
    [No Abstract]   [Full Text] [Related]  

  • 33. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Duration of second remission of Hodgkin's disease in children. Results of treatment achieved by the Polish Leukemia and Malignant Lymphoma Therapy in Children Group].
    Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Radwańska U; Kaczmarek M; Ochocka M; Stańczak E; Sońta-Jakimczyk D; Bogusławska-Jaworska J
    Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):924-8. PubMed ID: 1845709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
    Wilder RB; Schlembach PJ; Jones D; Chronowski GM; Ha CS; Younes A; Hagemeister FB; Barista I; Cabanillas F; Cox JD
    Cancer; 2002 Mar; 94(6):1731-8. PubMed ID: 11920535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
    Jenkin D; Doyle J
    Cancer Treat Res; 1989; 41():247-56. PubMed ID: 2577078
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
    Casini M; Pianezze G; Fabris P; Cemin S; Coser P
    Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
    [No Abstract]   [Full Text] [Related]  

  • 39. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
    Baĭsogolov GD; Shakhtarina SV; Afanasova NV
    Med Radiol (Mosk); 1991; 36(8):4-7. PubMed ID: 1890940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.